Related by context. All words. (Click for frequent words.) 82 R #Y ibritumomab 72 Immunotherapeutic 71 bevacizumab Avastin ® 71 Azacitidine 71 oral prodrug 71 Paraplatin ® 71 dihydrochloride 71 SPRYCEL ® 70 cetuximab Erbitux R 70 TO AVOID PREGNANCY WHILE 70 IL# PE#QQR 70 Granulocyte Colony Stimulating Factor 70 dasatinib Sprycel 70 Tiuxetan 70 CYT# potent vascular disrupting 70 metastatic malignant 70 liposomal formulation 69 myelodysplastic myeloproliferative diseases 69 ibritumomab tiuxetan 69 docetaxel Taxotere ® 69 Ibritumomab Tiuxetan 69 5 fluorouracil leucovorin 69 receptor tyrosine kinase inhibitor 69 MAGE A3 ASCI 69 Clolar ® 69 novel VDA molecule 69 #Y ibritumomab tiuxetan 69 TLK# 69 Percutaneous Transluminal Coronary Angioplasty 69 monoclonal antibody conjugated 69 Neulasta ® 69 ZEVALIN ® 69 biliary tract cancer 69 vapreotide acetate 69 refractory chronic lymphocytic 69 PKC# 69 IMiDs ® compound 69 Mycophenolate Mofetil 69 sorafenib tablets 69 Initiate Clinical Trial 69 pan HDAC inhibitor 69 malignant ascites 69 Patients Treated With 69 Copegus ribavirin 68 Intravitreal 68 generation purine nucleoside 68 erlotinib Tarceva ® 68 histamine dihydrochloride 68 Vidaza ® 68 Achieves Primary Endpoint 68 PNP inhibitor 68 mertansine 68 YONDELIS 68 TNF Tumor Necrosis Factor 68 bortezomib Velcade 68 Posaconazole 68 catheter occlusion 68 gefitinib Iressa 68 Ozarelix 68 Adjuvant Treatment 68 Myocet 68 MOVIPREP R 68 targeted radiotherapeutic 68 iobenguane 68 Vidaza azacitidine 68 bevacizumab Avastin R 68 Anthracycline 68 Natalizumab 68 histone deacetylase inhibitor 68 Personalized Immunotherapy 68 PEGylated anti 68 chimeric monoclonal antibody 68 Fludara ® 67 acetonide FA 67 Pegylated 67 Angiotensin Converting Enzyme 67 evaluating tivozanib 67 orally administered inhibitor 67 R Saizen R 67 indinavir Crixivan 67 Fondaparinux 67 Meets Primary Endpoint 67 gastrointestinal stromal tumors GIST 67 5 FU leucovorin 67 fallopian tube cancers 67 uricase 67 Parathyroid Hormone 67 Medoxomil 67 cinacalcet 67 FUSILEV enhances 67 Neoadjuvant 67 Nebulized 67 NAVISTAR R 67 sorafenib Nexavar 67 idarubicin 67 carmustine 67 Serostim R 67 HuMax EGFr 67 LHRH receptor positive 67 FEMALES SHOULD BE ADVISED 67 relapsing remitting MS RRMS 67 standard chemotherapy regimen 67 recurrent glioblastoma multiforme 67 PEGylated interferon 67 EP #R 67 Recombinant Human 67 induced macular edema 67 EGFR TKI 67 ara C 67 Cetuximab Erbitux 67 Taxol ® 67 targeted antifolate 67 Complicated Skin 67 Temsirolimus 67 chronic eosinophilic leukemia 67 Nilotinib 67 CD3 monoclonal antibody 67 abacavir Ziagen 67 chemotherapy cisplatin 67 Trastuzumab 67 Dalbavancin 67 Irinotecan 67 Inhalation Solution 67 AVONEX ® 67 imatinib Gleevec 67 Squalamine 67 Mitoxantrone 67 Onalta TM 67 Phase IIb Trial 67 metastatic GIST 67 PRN FDA Approves 67 Bezielle 67 metastatic colorectal 67 AAG geldanamycin analog 67 pegfilgrastim 67 thalidomide Thalomid 66 Mitomycin C 66 antimetabolite 66 ALN TTR# 66 docetaxel Taxotere R 66 demethylating agent 66 Zorbtive TM 66 Cloretazine 66 Fludarabine 66 ® lenalidomide 66 Prolongs Survival 66 cetuximab Erbitux ® 66 FOLOTYN ® 66 Preclinical studies suggest 66 Methylnaltrexone 66 luteinizing hormone releasing 66 Dasatinib 66 Pemetrexed 66 antibody MAb 66 complement inhibitor eculizumab 66 Tarceva TM 66 alfa 2b 66 Alocrest 66 PEGINTRON TM 66 trastuzumab DM1 T DM1 66 SUPPRELIN R LA 66 interferon gamma 1b 66 hormone LHRH antagonist 66 potent CYP#A# inhibitors 66 treat benign prostatic 66 histone deacetylase HDAC inhibitor 66 Aplidin 66 Known hypersensitivity 66 Metastatic Melanoma 66 sublingual tablets 66 Factor VIIa 66 protein tyrosine phosphatase 1B 66 cediranib 66 Liposomal 66 Mg Uk 66 secondary hyperparathyroidism 66 Lenalidomide 66 Antiangiogenic 66 Oxaliplatin 66 cisplatin gemcitabine 66 ciprofloxacin hydrochloride 66 PEG interferon 66 IV Busulfex 66 CYP#A# CYP#D# 66 pan histone deacetylase 66 Chemophase 66 Orally administered 66 BrachySil TM 66 vinca alkaloid 66 Pertuzumab 66 Saizen R 66 Pegylated interferon 66 itraconazole Sporanox 66 APTIVUS 66 Xanafide 66 Anti VEGF 66 AGGRASTAT R Injection tirofiban 66 Pharmacokinetics PK 66 Decitabine 66 Calcitonin 66 Xyfid TM 66 Antitumor Activity 66 Platinol ® cisplatin 66 Pazopanib 66 ZOLINZA 66 ceftazidime 66 chemosensitizer 66 Panzem R NCD 66 forodesine 66 Interferon beta 66 Naive Patients 66 pegylated interferon alpha 2a 66 Hormone Refractory Prostate Cancer 66 systemic anaplastic large 66 Arsenic trioxide 66 formerly LymphoStat B 66 metaglidasen 66 AEG# 66 vinorelbine tartrate 66 intradermal injection 66 Peginterferon alfa 2b 66 diarrhea predominant irritable 66 Helicobacter pylori eradication 66 hypereosinophilic syndrome 66 concurrent chemoradiation 66 radiotherapeutic 66 alkylating agent 66 Wafer polifeprosan 66 oxaliplatin Eloxatin 66 antibody MT# 66 Pegylated Interferon 66 Estrogen Receptor 66 caspofungin 66 riociguat 66 Ranolazine 66 2 methoxyestradiol 66 Leukine ® 66 FDA APPROVES 66 PEGylated Fab fragment 66 invasive candidiasis 66 dasatinib Sprycel ® 66 Phase 2b Clinical Trial 66 HuLuc# 66 taxane resistant 66 Vidaza R 66 Capesaris 66 Allogeneic 66 peripherally acting 66 ORENCIA ® 66 trabectedin 66 Peginterferon 65 paclitaxel Taxol R 65 advanced metastatic renal 65 CIMZIA TM certolizumab pegol 65 myelofibrosis polycythemia vera 65 Octreotide 65 Kinase Inhibitor 65 Azedra 65 Bosutinib 65 Cytotoxic 65 albumin bound paclitaxel 65 Saquinavir 65 Saizen ® 65 arsenic trioxide injection 65 refractory cutaneous T 65 FS Antihemophilic Factor Recombinant 65 Trial Evaluating 65 HuMax CD4 65 selective modulator 65 essential thrombocythemia ET 65 Lubiprostone 65 Bevacizumab 65 Civacir 65 GTC recombinant human 65 cyclophosphamide methotrexate 65 Radioimmunotherapy 65 intravesical instillation 65 CTAP# Capsules 65 Pivotal Phase 65 Factor Receptor 65 corticosteroid dexamethasone 65 Hsp# Inhibitor 65 relapsed MM 65 efaproxiral 65 PDX pralatrexate 65 Gliadel Wafer 65 nucleoside analog 65 BENLYSTA ® 65 papillary renal cell carcinoma 65 rhITF 65 metastatic neuroendocrine tumors 65 acyclovir Lauriad R 65 investigational monoclonal antibody 65 Mg Usa 65 HepDirect prodrug 65 methylnaltrexone bromide 65 nilotinib Tasigna 65 Pegylated Liposomal Doxorubicin 65 Camptosar ® 65 Vascugel 65 Cyclosporine 65 CD# monoclonal antibody 65 Ophena 65 Adjunctive 65 IN PATIENTS WITH 65 alfa 2a 65 ritonavir boosted 65 thetreatment 65 Traficet EN 65 velafermin 65 TYGACIL 65 Adult Stem Cell Therapy 65 reteplase 65 echinocandin 65 zoledronate 65 Gonal f ® 65 SIR Spheres 65 See CLINICAL PHARMACOLOGY 65 XL# XL# 65 Phase #b/#a clinical 65 ADP receptor antagonist 65 FOR FURTHER INFORMATION ABOUT 65 humanised monoclonal antibody 65 trastuzumab Herceptin R 65 beta 1a 65 Advanced Renal Cell 65 microsphere therapy 65 HGS ETR2 65 colony stimulating factor 65 ergot derivatives 65 HDAC Inhibitor 65 SPRIX ® 65 Dual Opioid 65 adriamycin 65 liposomal doxorubicin 65 DUROS 65 Bortezomib 65 panitumumab Vectibix R 65 small molecule thrombopoietin 65 pegylated liposomal doxorubicin 65 hormone agonist 65 antifolates 65 IAP inhibitor 65 clodronate 65 Phase III Clinical Trial 65 amikacin 65 Navelbine ® 65 AVASTIN 65 herpetic keratitis 65 Tacrolimus 65 Antitumor 65 gemcitabine Gemzar 65 Zevalin R Ibritumomab 65 evaluating picoplatin 65 liposomal amphotericin B 65 Interferon beta 1a 65 Bazedoxifene 65 Fc fusion protein 65 leukemia AML 65 Gleevec imatinib mesylate 65 topically administered 65 reslizumab 65 Prospective Randomized 65 Combination REOLYSIN R 65 pentostatin 65 transarterial 65 novel emulsion formulation 65 murine model 65 intravesical infusion therapy 65 sitaxsentan 65 BrachySil ™ 65 Gliadel R 65 Tyrosine Kinase Inhibitor 65 JAK2 inhibitor 65 Initiates Clinical Trial 65 Noxafil 65 DURECT proprietary 65 PDE4 inhibitor 65 Dapagliflozin 65 Interferon Beta 65 ELACYT 65 Relapsed Refractory 65 intranasal formulation 65 Panzem NCD 65 Interferon Gamma 65 DNA demethylating agent 65 DDP# 65 CINTREDEKIN BESUDOTOX 65 Aurora Kinase 65 dexamethasone Decadron 65 evaluating satraplatin 65 lexidronam injection 65 MGd 65 Valopicitabine 65 trastuzumab Herceptin 65 VNP#M 65 Elagolix 64 R bisoprolol Euthyrox 64 Onalta ™ 64 Luteinizing Hormone Releasing Hormone 64 humanized monoclonal 64 Solazed TM 64 alkylating 64 investigational humanized monoclonal antibody 64 Hydrochloride Injection 64 sapropterin dihydrochloride 64 novel topoisomerase 64 brand ciclesonide HFA 64 polycythemia vera essential thrombocythemia 64 Inhalation Aerosol 64 POSIDUR TM 64 TAXOTERE R 64 Pafuramidine 64 Surgical resection 64 Replacement Therapy 64 GRASPA ® 64 FOLFOX6 chemotherapy regimen 64 PrevOnco 64 fosbretabulin 64 Bendamustine 64 Losartan 64 Microplasmin 64 ribavirin RBV 64 INVANZ 64 samarium Sm 64 subcutaneous immunoglobulin 64 LEUKINE 64 assessing T DM1 64 Hycamtin ® 64 farletuzumab 64 BCR ABL inhibitor 64 flutamide 64 BUPHENYL R 64 Myelodysplastic Syndrome MDS 64 IMiDs R 64 non nucleoside inhibitor 64 cilengitide 64 Single Dose 64 systemic RNAi therapeutic 64 Oral Mucositis 64 Cardiotoxicity 64 Amrubicin 64 INTEGRILIN ® 64 cytostatic 64 OMNARIS HFA 64 xanthine oxidase inhibitor 64 pharmacologically active isomer 64 GVAX ® 64 chemotherapeutic regimen 64 Carboplatin 64 imatinib Gleevec ® 64 ONCASPAR 64 corifollitropin alfa 64 Vincristine 64 novel histone deacetylase 64 microtubule inhibitor 64 Microspheres 64 R roscovitine CDK cyclin 64 Interferon Alfa 64 CTAP# 64 HGS ETR1 mapatumumab 64 vaginal candidiasis 64 IAP inhibitors 64 relapsed ovarian cancer 64 Serostim ® 64 ALN HPN 64 fludarabine cyclophosphamide 64 Gleevec Glivec 64 Upregulation 64 Gonal f R 64 liposome encapsulated 64 proteasome inhibitor 64 RECOTHROM R 64 etanercept Enbrel 64 LEP ETU 64 Systemic Delivery 64 vidofludimus 64 panitumumab Vectibix 64 candesartan cilexetil 64 Marqibo TM 64 G#DT 64 Dacogen decitabine 64 antiangiogenic drugs 64 Cutaneous T 64 interferon beta 1a infertility 64 piperacillin tazobactam 64 Randomized Phase 64 EOquin TM 64 FASLODEX 64 huC# DM4 64 Chemoradiation 64 cutaneous T 64 Follicular Lymphoma 64 small molecule tyrosine 64 adefovir dipivoxil 64 lymphoid malignancies 64 hyperphenylalaninemia HPA due 64 plus DOXIL 64 paclitaxel Taxol 64 metastatic castration resistant 64 trans retinoic acid 64 administered concomitantly 64 COPEGUS R 64 recurrent metastatic 64 Nexavar ® 64 R lenalidomide 64 Shows Statistically Significant 64 Ixempra 64 Epidermal Growth Factor Receptor 64 Pivotal Phase III 64 Copegus ® 64 Intra arterial 64 FUSILEV ® 64 hA# 64 mesylate 64 dextromethorphan quinidine 64 Cx# [002] 64 BCG refractory carcinoma 64 Mipomersen 64 Prodarsan R 64 BAL# [002] 64 aspirin clopidogrel 64 unresectable tumors 64 TELINTRA 64 Epirubicin 64 immunotherapeutic vaccine 64 subcutaneous formulation 64 Nonsurgical 64 targeting CD# 64 Gleevec resistant 64 temsirolimus Torisel 64 Platinol ® 64 kidney urologic 64 Allovectin 7 64 Yondelis ® 64 ChronVac C R 64 Gonal f R follitropin 64 compound AEZS 64 SNT MC# 64 ixabepilone 64 verteporfin 64 Cytarabine 64 hMG 64 Glufosfamide 64 Romidepsin 64 GW# [003] 64 trimethoprim sulfamethoxazole 64 cell lymphoma CTCL 64 CYT# QbG# 64 esophageal gastric 64 TRISENOX ® 64 familial amyloidotic polyneuropathy FAP 64 Deforolimus 64 potent inducers 64 sunitinib Sutent 64 Plasmin 64 Degarelix 64 lenalidomide Revlimid R 64 meropenem 64 Epratuzumab 64 JAK inhibitor 64 HER2 positive metastatic breast 64 nonnucleoside reverse transcriptase inhibitors 64 CYP#A# inhibitors 64 EGFR HER2 64 IMA# 64 Gemzar gemcitabine 64 ACTEMRA TM 64 Previously Untreated 64 Neupogen ® 64 pyrazinamide 64 Monotherapy 64 mRCC 64 Lauriad 64 MYLOTARG 64 FOLFOX6 64 uric acid lowering 64 MEK Inhibitor 64 anti angiogenic agents 64 Opterone R 64 Azathioprine 64 non resectable 64 XYNTHA 64 LymphoStat B belimumab 64 rFSH 64 bronchoalveolar lavage 64 bladder carcinoma 64 candidates Azedra TM 64 synthetic peptide containing 64 estramustine 64 Elotuzumab 64 Ecallantide 64 VALSTAR 64 Betaferon R 64 subependymal giant cell 64 anthracycline chemotherapy 64 epithelial tumors 64 sunitinib malate 64 BAY #-# 64 vascular disrupting agents 64 Vinorelbine 64 rhBMP 2 64 lucinactant 64 Novel Oral 64 MYCAMINE 64 alvespimycin 64 platelet inhibitor 64 Tasimelteon 64 mTOR inhibitors 64 Rituximab 64 HSP# inhibitor 64 pregabalin Lyrica 64 lanthanum carbonate 64 Moxifloxacin 64 oral picoplatin 64 Kepivance 64 daunorubicin 64 Aflibercept 64 Zemiva TM 64 MTP inhibitor 64 intracavitary 64 quinolone 64 tuberous sclerosis TS 64 Kinoid 64 chemotherapy FOLFOX 63 Alferon LDO 63 aripiprazole Abilify 63 Lenocta 63 Vitaxin 63 multicenter Phase II 63 posaconazole 63 fallopian tube carcinoma 63 immunotherapeutic agent 63 Abatacept 63 IgG1 monoclonal antibody 63 zoledronic acid Zometa 63 rituximab Rituxan 63 transplantation HCT 63 NeuroSTAT ® 63 cidofovir 63 PROCTOCORT R 63 non splenectomized 63 LB# [003] 63 acute peripheral arterial 63 direct thrombin inhibitors 63 5 Fluorouracil 63 DELATESTRYL R 63 bexarotene 63 tumor xenograft models 63 dorzolamide 63 phase IIb clinical 63 Brentuximab Vedotin SGN 63 XYOTAX TM 63 LymphoStat B TM 63 oncolytic virus therapies 63 Omacetaxine 63 LHRH agonist 63 R metformin Concor 63 GATTEX TM 63 transthyretin TTR mediated amyloidosis 63 haematopoietic 63 intranasal delivery 63 Kit CD# positive 63 anti CD3 63 micafungin 63 Mepact 63 alefacept 63 Filgrastim 63 nucleotide analog 63 Ganciclovir 63 plasmid encoding 63 Patients Receiving 63 Parathyroid hormone 63 Sustiva efavirenz 63 Erlotinib 63 sodium glucose cotransporter 63 colorectal adenoma 63 MKC# MT 63 ThermoDox R 63 benzoic acid hyoscyamine sulfate 63 ALA PDT 63 SinuNase TM 63 tyrosine kinase inhibitor 63 Cisplatin 63 tigecycline 63 Cleviprex TM clevidipine 63 Xeloda ® 63 interleukin IL -# 63 J Am Coll 63 Initiate Phase 63 basiliximab 63 radiofrequency ablation RFA 63 Tazorac 63 pamidronate 63 vorinostat 63 prescribed proton pump 63 5 HT3 antagonist 63 cromolyn sodium 63 rHuPH# recombinant human 63 Panzem R 63 Golimumab 63 Leucovorin 63 Ventavis ® 63 Proellex TM 63 tubulin inhibitor 63 HepaSphere 63 mitomycin C 63 Randomized Phase II 63 inhibitor RG# 63 substrates inhibitors 63 Exelixis compounds 63 Hepatocellular Carcinoma HCC 63 AERx ® 63 Vandetanib 63 docetaxel Taxotere 63 thrombin inhibitor 63 JAK2 Inhibitor 63 LHRH antagonist 63 Pivotal Trial 63 radiation enteritis 63 NXL# 63 constipation OIC 63 Nexavar sorafenib 63 isoform selective 63 esophageal carcinoma 63 systemic immunosuppressive drugs 63 Danazol 63 stage IIIB 63 oral methylnaltrexone 63 TYZEKA 63 II Clinical Trial 63 QUADRAMET R 63 ATRA IV 63 PSMA ADC 63 GnRH agonist 63 anticholinergic agents 63 cancer mCRC 63 Anti Tumor 63 telomerase therapeutic 63 Quinamed 63 JAK1 63 DAVANAT 63 acid phosphatase PAP 63 injectable bulking agent 63 pain palliation 63 Thrombin 63 Xelox 63 ELOXATIN 63 BARACLUDE R 63 Rebif ® 63 Liprotamase 63 anthracycline taxane 63 metabolic disorders Saizen R 63 Ceflatonin 63 EndoTAG 63 OHR/AVR# 63 cell carcinoma RCC 63 Akt inhibitor 63 budesonide foam 63 poly ADP ribose polymerase 63 Kuvan sapropterin dihydrochloride 63 sodium thiosulfate STS 63 Abrupt discontinuation 63 induced anemia 63 Leukemias 63 Sevelamer 63 TroVax ® 63 Teriparatide 63 ATL# [001] 63 oral rivaroxaban 63 pharmacokinetic PK study 63 Sanofi Aventis Taxotere 63 Neulasta R 63 diabetic gastroparesis 63 injected subcutaneously 63 HDACi 63 Vaprisol 63 cardiometabolic diseases Glucophage 63 endocrine therapies 63 PRT# 63 ALN PCS 63 CR# vcMMAE 63 Everolimus 63 vaginally administered lidocaine 63 gemtuzumab ozogamicin 63 RhuDex ® 63 mitoxantrone plus 63 acyclovir Lauriad ® 63 lutropin alfa 63 RFF Pen 63 imatinib resistant 63 Insegia 63 Taclonex R 63 Cloretazine ® 63 amifostine 63 Abciximab 63 tumors GIST 63 including eniluracil ADH 63 mitogen activated ERK kinase 63 Annamycin 63 somatropin Kuvan R 63 LHRH 63 Cystectomy 63 denileukin diftitox 63 Herceptin trastuzumab 63 H2 antagonists 63 YONDELIS R 63 imatinib mesylate 63 ganetespib 63 INCB# [001] 63 amprenavir 63 sunitinib Sutent ® 63 octreotide acetate 63 Kahalalide F 63 abacavir lamivudine 63 infusional 5-FU/LV 63 Fluconazole 63 hormone refractory metastatic prostate 63 OvaRex R 63 Triapine 63 Zavesca R 63 TRX1 63 novel peptide 63 volociximab 63 HER2 overexpression 63 Sandimmune 63 CLORETAZINE TM VNP#M 63 orally inhaled migraine 63 Demonstrates Significant 63 Bosentan 63 AZILECT ® 63 neo adjuvant 63 anti angiogenic agent 63 gastric adenocarcinoma 63 AQ4N 63 IMiDs 63 Piperacillin 63 Anidulafungin 63 emtricitabine tenofovir 63 Advanced Melanoma 63 orally dosed 63 TRO# 63 sulfonamide 63 HepaGam B 63 hypocalcaemia 63 Accelerated Partial Breast Irradiation 63 sodium stibogluconate 63 EGFR tyrosine kinase inhibitor 63 humanized anti 63 antitumor effect 63 lapatinib Tykerb 63 selective antagonist 63 Aliskiren 63 DNA intercalator 63 adjuvant trastuzumab 63 clotrimazole 63 xenograft models 63 R sorafenib tablets 63 fluoropyrimidine 63 tropism testing 63 Myelodysplastic Syndromes 63 ACE Inhibitors 63 Amgen Neulasta R 63 entinostat 63 inhaled iloprost 63 carcinoma HCC 63 orally inhaled 63 prostate cancer HRPC 63 Tamibarotene 63 galiximab 63 Trabectedin 63 insulin glulisine 63 Genentech Rituxan 63 prokinetic agent 63 Hematopoietic 63 Sapacitabine 63 antiplatelet agent 63 Evoltra ® 63 alpha 2a 63 Intravascular 63 paclitaxel poliglumex 63 potent antiproliferative 63 biologic DMARD 63 cisplatin resistant 63 Study Evaluating 63 potentially hepatotoxic 63 unresectable inoperable 63 Fluorouracil 63 Velcade bortezomib 63 busulfan 63 Phase III Pivotal 63 chemoradiation therapy 63 selective immunoproteasome inhibitor 63 IMiDs ® 63 REVLIMID R 63 Breast Cancer Assay 63 proteasome inhibitor bortezomib 63 conventional DMARDs 63 haematological malignancies 63 Olmesartan 63 CIMZIA R 63 STRIDE PD 63 ® bortezomib 63 erlotinib Tarceva 63 Amphotericin B 63 Darinaparsin 63 platinum chemotherapeutic 63 Is Well Tolerated 63 evaluating T DM1 63 Melphalan 63 Kuvan R 63 metaplasia 63 Alfacell proprietary ribonuclease 63 Vitrasert R 63 pathophysiological effects 63 Investigational Treatment 63 Doxil ® 63 pegylated interferon alfa 2a 63 esophageal candidiasis 63 Proxinium TM 63 BUPHENYL R sodium phenylbutyrate 63 Carfilzomib 63 lamotrigine Lamictal 63 OMP #R# 63 5alpha reductase 63 oral JAK1 63 IRX 2 63 interferon alfa 2b 63 HuMax 63 prostatic tissue 63 MyVax R 63 Diabetic Neuropathy 63 CIMZIA ™ 63 either acutely decompensated 63 AVAPRO 63 Immunomodulatory 63 Interferon alfa 63 miconazole Lauriad ® 63 Maribavir 63 Hexvix ® 63 INCB# [003] 63 Protease Inhibitor 63 Cimzia ® certolizumab pegol 63 Catena ® 63 pancreatic enzyme replacement 63 fluorouracil leucovorin 63 polycythemia vera PV 63 Corgentin 63 Bone Morphogenetic Protein 63 bevacizumab Avastin 62 using Innocoll proprietary 62 mixed hyperlipidemia 62 MVA BN 62 Argatroban 62 demonstrated antitumor activity 62 Inhaled nitric oxide 62 lumiliximab 62 Daclizumab 62 CONTRAINDICATIONS 62 TNF alpha selectively neutralizing 62 metastatic gastric 62 ORENCIA R 62 monoclonal antibody IgG1 Mab 62 mycophenolate mofetil 62 Plus Ribavirin 62 Intravenous Human 62 TRANSDUR ™ 62 rilonacept 62 TRISENOX 62 indinavir 62 relapsing multiple sclerosis 62 immunomodulating 62 PEG IFN 62 PROSTASCINT R 62 Bicalutamide 62 fluoroquinolone antibiotic 62 Pfizer Camptosar 62 tazobactam 62 GRN# 62 castrate resistant 62 oral antiviral 62 pioglitazone HCl 62 calcineurin inhibitor 62 fibrin deposition 62 topical ocular 62 RNAi therapeutic targeting 62 bladder ovarian 62 Actimmune ® 62 Granted Orphan Drug 62 thyroid carcinoma 62 colorectal cancer liver metastases 62 ABLYNX 62 Completes Patient Enrollment 62 DURIN TM 62 bendamustine 62 saline placebo 62 PANVAC VF 62 betamethasone dipropionate 62 lipid lowering agents